Drug and medical device knowledge company, First Databank (FDB) is urging GP practices to standardise their approaches to routine testing and monitoring of drugs, after its data revealed variance in compliance across key safety indicators for drug prescriptions.
from News from healthcareitnews.com https://ift.tt/34MpFC7
via IFTTT
Sunday, November 10, 2019
Home »
News from healthcareitnews.com
» Wide variance in safety indicator drug monitoring by GP practices in England and Wales revealed in new data







0 comments:
Post a Comment